Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials Source: PMC / BioMed Central Summary: A systematic review of Phase I/II trials evaluating intravenous vitamin C (ascorbate) in cancer settings, noting safety, tolerability, and potential clinical efficacy (often as an adjunct to chemotherapy)
Abstract: Collagen hydrolysate, which contains bioactive peptides, is used as a dietary supplement for the refinement of elasticity, hydration, desquamation, and wrinkling of aging human skin
These insights open new avenues for research into pathogenesis and the investigation of targeted approaches based on the modulation of proteasomal function
This direct delivery is why the timeline for injections is often measured in days rather than weeks, especially for someone who was deficient
Anselmo, A
Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al